MPLX LP MPLX 深 滬
等待開盤 06-26 09:30:00 美东时间
56.07
-0.160
-0.28%
華盛通- 最 高57.20
- 今 開56.20
- 成交量 153.30万股
- 最 低 56.05
- 昨 收 56.23
- 總市值 568.96亿
- 52周最高 58.9035
- 市盈率 靜 11.64
- 換手率 0.15%
- 52周最低 44.5705
- 委 比 -58.14%
- 總股本 10.15亿
- 歷史最高 58.9035
- 量 比 0.91
- 振 幅 2.05%
- 歷史最低 -14.303
- 每 手 1
- 風險率 4.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MPLX schedules second-quarter results conference call
MPLX schedules second-quarter results conference call MPLX will report 2026 second-quarter results on Aug. 4, 2026. A conference call is scheduled for Aug. 4 at 9:30 a.m. EDT, with a webcast at https://www.mplx.com . Disclaimer: This news brief was created by Public Technologies (PUBT) using generat
06-16 18:50
Kayne Anderson Energy Infrastructure Fund Reports May NAV of $15.70, Says Net Assets Were $2.7B at End of May
Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company") (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the
06-03 16:21
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information And Announces Its Net Asset Value And Asset Coverage Ratios As Of May 31, 2026
Kayne Anderson Energy Infrastructure Fund reported net assets of $2.7 billion as of May 31, 2026, with a net asset value per share of $15.70. The company's asset coverage ratios under the 1940 Act were 644% for senior securities and 497% for total leverage. The portfolio is primarily invested in midstream energy companies (94%), with long-term investments totaling $3.74 billion. The top holdings include Enterprise Products Partners, Energy Transf...
06-03 00:01
美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
Ted Oakley Says Wall Street Is Chasing The AI 'Dream' While Ignoring 'Mispriced' Energy Stocks
Ted Oakley warns the AI tech boom is a 'dream.' Find out why he says to 'buy energy first' and reveals his top mispriced dividend stocks.
05-20 14:39
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Barclays Maintains Overweight on MPLX, Raises Price Target to $59
Barclays analyst Theresa Chen maintains MPLX (NYSE:MPLX) with a Overweight and raises the price target from $58 to $59.
05-14 21:41
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
